Immunogenik, Inc.

Immunogenik, Inc. is a cutting-edge biotherapeutic company focused on developing innovative cancer immunotherapy platforms designed to improve patient outcomes. Immunogenik, Inc. is committed to pioneering advancements in cancer treatment, ensuring that its therapeutic solutions are both effective and patient-centric.

Located at 747 SW 2nd Avenue, Suite 321, Box 57, Gainesville, FL 32601, US, Immunogenik, Inc. is dedicated to translating groundbreaking research into tangible clinical benefits. The company's mission is to revolutionize cancer care through the development of novel immunotherapies that offer hope and improved quality of life for patients battling cancer.

With a focus on innovation and patient well-being, Immunogenik, Inc. is poised to make a significant impact in the field of cancer immunotherapy. We invite the management team at Immunogenik, Inc. to enhance your company's visibility and commercial potential by creating a customized and exclusive company showcase and product listing on our platform.